Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by Lyell Wealth Management LP

Lyell Wealth Management LP lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 33,706 shares of the medical equipment provider’s stock after acquiring an additional 243 shares during the period. Intuitive Surgical accounts for approximately 1.3% of Lyell Wealth Management LP’s holdings, making the stock its 20th biggest position. Lyell Wealth Management LP’s holdings in Intuitive Surgical were worth $11,371,000 at the end of the most recent reporting period.

Other institutional investors also recently made changes to their positions in the company. Vanguard Group Inc. lifted its stake in Intuitive Surgical by 0.7% during the third quarter. Vanguard Group Inc. now owns 29,868,227 shares of the medical equipment provider’s stock valued at $8,730,184,000 after purchasing an additional 196,316 shares during the last quarter. Jennison Associates LLC lifted its position in shares of Intuitive Surgical by 6.4% in the 3rd quarter. Jennison Associates LLC now owns 4,585,190 shares of the medical equipment provider’s stock valued at $1,340,205,000 after acquiring an additional 274,692 shares in the last quarter. Invesco Ltd. lifted its position in shares of Intuitive Surgical by 6.6% in the 3rd quarter. Invesco Ltd. now owns 3,750,490 shares of the medical equipment provider’s stock valued at $1,096,231,000 after acquiring an additional 232,205 shares in the last quarter. Northern Trust Corp lifted its position in shares of Intuitive Surgical by 3.4% in the 3rd quarter. Northern Trust Corp now owns 3,514,421 shares of the medical equipment provider’s stock valued at $1,027,230,000 after acquiring an additional 115,059 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its position in shares of Intuitive Surgical by 0.9% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 2,030,415 shares of the medical equipment provider’s stock valued at $593,470,000 after acquiring an additional 17,477 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Intuitive Surgical

In other news, SVP Mark Brosius sold 196 shares of the business’s stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $400.00, for a total value of $78,400.00. Following the sale, the senior vice president now owns 1,842 shares of the company’s stock, valued at $736,800. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In related news, EVP Myriam Curet sold 5,318 shares of the business’s stock in a transaction on Tuesday, April 23rd. The shares were sold at an average price of $370.66, for a total transaction of $1,971,169.88. Following the transaction, the executive vice president now directly owns 298 shares in the company, valued at $110,456.68. The sale was disclosed in a filing with the SEC, which is available through this link. Also, SVP Mark Brosius sold 196 shares of the company’s stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $400.00, for a total transaction of $78,400.00. Following the completion of the transaction, the senior vice president now owns 1,842 shares in the company, valued at $736,800. The disclosure for this sale can be found here. Insiders have sold a total of 255,736 shares of company stock valued at $98,639,667 over the last 90 days. 0.80% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on ISRG shares. Wells Fargo & Company upped their price target on shares of Intuitive Surgical from $363.00 to $416.00 and gave the company an “overweight” rating in a research report on Friday, January 19th. Piper Sandler increased their price target on shares of Intuitive Surgical from $425.00 to $435.00 and gave the stock an “overweight” rating in a research note on Friday, April 19th. Citigroup raised their target price on shares of Intuitive Surgical from $428.00 to $462.00 and gave the company a “buy” rating in a research note on Wednesday, April 3rd. Mizuho increased their price target on shares of Intuitive Surgical from $350.00 to $390.00 and gave the company a “neutral” rating in a report on Thursday, January 25th. Finally, StockNews.com downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Thursday, February 29th. Five research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average price target of $396.17.

Intuitive Surgical Trading Down 0.5 %

Shares of NASDAQ:ISRG traded down $2.07 during trading on Wednesday, hitting $375.01. 1,323,588 shares of the company’s stock were exchanged, compared to its average volume of 1,672,638. Intuitive Surgical, Inc. has a 1-year low of $254.85 and a 1-year high of $403.76. The firm has a 50-day moving average price of $386.40 and a two-hundred day moving average price of $345.19. The firm has a market cap of $133.02 billion, a P/E ratio of 67.69, a PEG ratio of 4.65 and a beta of 1.36.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 EPS for the quarter, topping the consensus estimate of $1.40 by $0.10. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The company had revenue of $1.89 billion during the quarter, compared to analysts’ expectations of $1.87 billion. During the same quarter in the previous year, the company earned $1.00 EPS. Intuitive Surgical’s revenue was up 11.5% on a year-over-year basis. As a group, research analysts predict that Intuitive Surgical, Inc. will post 4.93 EPS for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.